ACR · ASX

Acrux Limited (ASX:ACR)

AU$0.014

 0.0 (0.0%)
ASX:Live
03/10/2025 10:03:24 AM
HALO Ords HALO Growth HALO Earnings Momentum HALO Consensus Value GROWTH AUS +2
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

ACR Overview

ACR Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Weak

GARP

Very Weak

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About ACR

Website

Acrux Limited

Telephone

61.3.8379.0100

Address

103-113 Stanley Street West Melbourne, Victoria (VIC) 3003

Description

Acrux Ltd. operates as a pooled development fund that invests in pharmaceutical businesses. The firm develops and commercializes pharmaceutical products using unique technology to administer drugs through the skin. Its products brands include AXIRON, ELLAVIE & EVAMIST and RECUVYRA. The company was founded by Ross Dobinson and Barrie Charles Finnin in 1998 and is headquartered in West Melbourne, Australia.

ACR Price Chart

Key Stats

Market Cap

AU$5.73M

PE

6.80

EV/EBITDA

5.2

Dividends Overview

DIV Yield

.0%

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.01 - 0.06

Trade Value (12mth)

AU$2,514.00

1 week

0%

1 month

7.69%

YTD

-57.58%

1 year

-74.07%

All time high

4.52

Key Fundamentals

EPS 3 yr Growth

-51.20%

EBITDA Margin

-714.60%

Operating Cashflow

-$5m

Free Cash Flow Return

-138.40%

ROIC

-150.40%

Interest Coverage

-28.00

Quick Ratio

1.10

Other Data

Shares on Issue (Fully Dilluted)

408m

HALO Sector

Healthcare

Next Company Report Date

21-Aug-26

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

ACR Announcements

Latest Announcements

Date Announcements

30 September 25

Notification of AGM date and nomination of directors

×

Notification of AGM date and nomination of directors

22 September 25

Notification regarding unquoted securities - ACR

×

Notification regarding unquoted securities - ACR

04 September 25

Received $3.04m RDTI rebate for FY25

×

Received $3.04m RDTI rebate for FY25

29 August 25

Appendix 4E and Full Year Statutory Accounts FY25

×

Appendix 4E and Full Year Statutory Accounts FY25

29 August 25

Appendix 4G and Corporate Governance Statement FY25

×

Appendix 4G and Corporate Governance Statement FY25

31 July 25

Licensing partnership in Saudi Arabia for Dapsone 5%, Gel

×

Licensing partnership in Saudi Arabia for Dapsone 5%, Gel

30 July 25

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

03 July 25

Application for quotation of securities - ACR

×

Application for quotation of securities - ACR

03 July 25

Notification of cessation of securities - ACR

×

Notification of cessation of securities - ACR

03 July 25

Receipt of second advance for FY25 R&D Tax Incentive

×

Receipt of second advance for FY25 R&D Tax Incentive

30 June 25

Change in substantial holding

×

Change in substantial holding

02 June 25

App 3X, Warmbrunn

×

App 3X, Warmbrunn

02 June 25

App 3Z, Kotsanis

×

App 3Z, Kotsanis

23 May 25

Notification of cessation of securities - ACR

×

Notification of cessation of securities - ACR

23 May 25

Application for quotation of securities - ACR

×

Application for quotation of securities - ACR

23 May 25

Appendix 3Y Brumley

×

Appendix 3Y Brumley

09 May 25

Dapsone 7.5%, Gel launched in the United States

×

Dapsone 7.5%, Gel launched in the United States

07 May 25

Acrux CEO and Managing Director appointment

×

Acrux CEO and Managing Director appointment

30 April 25

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

09 April 25

Details of Share Registry address

×

Details of Share Registry address

04 April 25

Application for quotation of securities - ACR

×

Application for quotation of securities - ACR

04 April 25

Appendix 3Y Dobinson

×

Appendix 3Y Dobinson

03 April 25

Acrux receives $1.73m advance on FY25 R&D Tax Incentive

×

Acrux receives $1.73m advance on FY25 R&D Tax Incentive

07 March 25

Attaching Options final application date 31 March 2025

×

Attaching Options final application date 31 March 2025

06 March 25

Notification of cessation of securities - ACR

×

Notification of cessation of securities - ACR

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

.0%

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

ACR Shortsell

Frequently Asked Questions

The current share price of Acrux Limited (ACR:ASX) is AU$0.014.
The 52-week high share price for Acrux Limited (ACR:ASX) is AU$0.06.
The 52-week low share price for Acrux Limited (ACR:ASX)? is AU$0.01.
The current TTM dividend payout for Acrux Limited (ACR:ASX) is 0.00.
The last dividend payment of Acrux Limited (ACR:ASX) is AU$0.06.
Acrux Limited (ACR:ASX) has a franking level of 0.0%.
Acrux Limited (ACR:ASX) is classified in the Healthcare.
The current P/E ratio for Acrux Limited (ACR:ASX) is 6.80.
The current share price of Acrux Limited (ACR:ASX) is AU$0.014.
The 52-week high share price for Acrux Limited (ACR:ASX) is AU$0.06.
The 52-week low share price for Acrux Limited (ACR:ASX)? is AU$0.01.
The current TTM dividend payout for Acrux Limited (ACR:ASX) is 0.00.
The last dividend payment of Acrux Limited (ACR:ASX) is AU$0.06.
Acrux Limited (ACR:ASX) has a franking level of 0.0%.
Acrux Limited (ACR:ASX) is classified in the Healthcare.
The current P/E ratio for Acrux Limited (ACR:ASX) is 6.80.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox
App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.

Ff